November 2, 2026
Oncology Pricing Reform and the Strategic Reset Ahead
Oncology pricing reform in India has moved from the courtroom to the gazette.…
October 26, 2026
Why the JCA Comparator Gap Still Shapes Access Outcomes
The JCA Comparator Gap has become one of the most consequential structural features…
October 19, 2026
Pharma Localisation Strategy and the Future of Sustainable Access
The recent presidential mandate for a government-business task force gives senior leaders a…
October 12, 2026
Prior MFP Anchors and the Quiet Retreat from Value
This article responds to "When Negotiated Prices Become The Benchmark: Prior MFPs And…
October 6, 2026
HEOR Strategic Shift: From Published Science to Decision Impact
The HEOR strategic shift means health economics and outcomes research has to change…
September 28, 2026
Transatlantic Pricing Loop Recasts How Leaders Price Access
The Transatlantic Pricing Loop is now a contractual fact rather than a policy…